Inventor
BERTINO JOSEPH R
US19 patents
⚠️ This page may combine multiple inventors who share the name “BERTINO JOSEPH R”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SLOAN KETTERING INST CANCER
8 patentsUS6204388B1Mar 20, 2001
Synthesis of epothilones, intermediates thereto and analogues thereof
SLOAN KETTERING INST CANCER143 citations98
US6642043B1Nov 4, 2003
Double mutants of dihydrofolate reductase and methods of using same
SLOAN KETTERING INST CANCER29 citations88
US6603023B2Aug 5, 2003
Synthesis of epothilones, intermediates thereto and analogues thereof
SLOAN KETTERING INST CANCER12 citations73
US6355639B1Mar 12, 2002
Reverse prenyl compounds as immunosuppressants
SLOAN KETTERING INST CANCER7 citations72
US6416987B1Jul 9, 2002
Mutants of thymidylate synthase and uses thereof
SLOAN KETTERING INST CANCER10 citations68
US6965034B2Nov 15, 2005
Synthesis of epothilones, intermediates thereto and analogues thereof
SLOAN KETTERING INST CANCER3 citations62
US6887467B1May 3, 2005
Double mutants of dihydrofolate reductase and methods of using same
SLOAN KETTERING INST CANCER0 citations48
US7514413B2Apr 7, 2009
In-vivo energy depleting strategies for killing drug-resistant cancer cells
SLOAN KETTERING INST CANCER1 citations46
UNIV RUTGERS
7 patentsUS10376597B2Aug 13, 2019
Targeting tumor cells with chemotherapeutic agents conjugated to matriptase antibodies
UNIV RUTGERS1 citations59
US9549993B2Jan 24, 2017
Specific delivery of toxins conjugated with antibodies to activate matripase
UNIV RUTGERS0 citations50
US11752215B2Sep 12, 2023
Targeting tumor cells with chemotherapeutic agents conjugated to anti-matriptase antibodies by in vivo cleavable linking moieties
UNIV RUTGERS0 citations49
US9849192B2Dec 26, 2017
Targeting tumor cells with chemotherapeutic agents conjugated to matriptase antibodies
UNIV RUTGERS1 citations49
US9682094B2Jun 20, 2017
Targeting matriptase expressing tumor cells with chemotherapeutic agents conjugated to matriptase antibodies
UNIV RUTGERS0 citations49
US11604133B2Mar 14, 2023
Use of multi-frequency impedance cytometry in conjunction with machine learning for classification of biological particles
UNIV RUTGERS0 citations46
US9314497B2Apr 19, 2016
E2F as a target of hormone refractory prostate cancer
UNIV RUTGERS0 citations45